The gap between operating income and net income, including the 2026Q1 $220.6M loss booked on positive operating income, implies impairments and tax items, not core operations, drive reported profitability, so the adjusted operating margin is the more defensible measure of earning power. However, with gross margin moving from 28.7% to 75.4% within two quarters, even that measure may reflect COGS recognition timing rather than structural wellhead economics, and investors should treat the 2026Q2 print of 48.0% operating margin skeptically until it repeats.

A persistently sub-4% ROIC on an asset base of roughly $1.3B, nearly all of it property and equipment, suggests the company has not earned its cost of capital over this window, pointing to capital efficiency rather than leverage as the binding constraint. The recent uptick from -3.1% in 2025Q3 to 3.5% may indicate a cyclical recovery in realizations, but with ROE simultaneously printing 9.4% off a shrinking equity base of $753.4M, the improvement should not yet be read as a durable compounding regime.

The deeply negative cycle means REI collects receivables in about 40 days while paying suppliers nearly a year later, which flatters short-term cash flow but may signal vendors are absorbing extended terms under pressure — a dynamic that warrants further investigation if payables normalize. Meanwhile, asset turnover of 0.05-0.08, roughly half what a typically more efficient E&P name would post, confirms that revenue generation per dollar of the $1.3B asset base remains structurally low.

D/E of 0.48 below peers appears comfortable, but D/EBITDA of 5.17 with cash of only $1.1M against $363.8M of debt leaves essentially no refinancing buffer, and coverage has proven erratic, printing -26.05 in 2026Q1 on a single weak quarter. Because EBITDA itself swings with crude realizations, investors should monitor covenant headroom under a lower price deck rather than extrapolating the current 3.15x coverage forward.

The sub-peer EV/EBITDA alongside a negative trailing P/E suggests the market is pricing a recovery in the company's own depressed EBITDA rather than paying a premium, which is typical for E&P names at cyclical troughs but exposes holders if realizations fade. The 0.35x price-to-book multiple, against retained earnings that have swung to -$126.8M, may indicate the market discounts reserve values below carrying cost; comparing REI on an EV/acre or EV/proved-reserve basis versus peers would test whether the apparent cheapness is structural or an artifact of the depressed equity base.